Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People [clinicaltrials:NCT00028366]
Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People [clinicaltrials:NCT00028366]
Bio2RDF identifier
NCT00028366
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00028366
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
Ritonavir (RTV) is a pr ...... e anti-HIV drug combinations.
brief title [clinicaltrials_vocabulary:brief-title]
Dual Versus Triple Protease In ...... onavir, in HIV Infected People
completion date [clinicaltrials_vocabulary:completion-date]
2005-07-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
A substantial proportio ...... ter starting study treatment.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2001-12-27T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Drug Therapy, Combination
HIV Protease Inhibitors
RNA, Viral
Reverse Transcriptase Inhibitors
Treatment Experienced
Viral Load
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2012-08-15T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00028366
official title [clinicaltrials_vocabulary:official-title]
A Randomized, Comparative Stud ...... th Virologic Treatment Failure
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
reference [clinicaltrials_vocabulary:reference]
responsible party [clinicaltrials_vocabulary:responsible-party]
secondary id [clinicaltrials_vocabulary:secondary-id]
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2012-08-01T00:00:00Z
identifier
clinicaltrials:NCT00028366
title
Dual Versus Triple Protease In ...... onavir, in HIV Infected People
@en
type
label
Dual Versus Triple Protease In ...... e [clinicaltrials:NCT00028366]
@en